Skip to content

Frontlight ResearchEarly access

Trial site

Gastro One /ID# 160373

Cordova, Tennessee 38018, United StatesNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Ulcerative colitis

Running trials

Active, not recruiting
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
NCT03398135· Phase 3· AbbVie· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Gastro One /ID# 160373: trial site – Frontlight Research